All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-CD79A DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-0287-CQ | HM47/A9 | Mouse | IgG1, κ | A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein | ||
DMAb-0288-CQ | HM57 | Mouse | IgG1 | Synthetic peptide corresponding to 202-216 amino acid sequence of human mb-1 | ||
DMAb-0289-CQ | IGA/1406 | Mouse | Human | IgG3 | A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein | |
DMAb-0290-CQ | IGA/1688R | Rabbit | IgG, κ | A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein | ||
DMAb-0291-CQ | IGA/515 | Mouse | Human | IgG1, κ | Recombinant Full length human IGA protein | |
DMAb-0292-CQ | IGA/764 | Mouse | Human | IgG1, κ | Recombinant human IGA protein | |
DMAb-0294-CQ | SPM550 | Mouse | IgG1, κ | A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein | ||
DMAb-0296-CQ | HM47 | Mouse | IgG1 | |||
DMAb-0298-CQ | RM297 | Rabbit | Human | IgG | A peptide corresponding to the C-terminus of human CD79a | |
DMAb-0303-CQ | SP18 | Rabbit | Human | IgG | Synthetic peptide derived from N-terminal region of human CD79a protein | |
DMAb-0296-CQ | HM47 | Mouse | IgG1, κ | Human CD79a | ||
DMAb-0288-CQ | HM57 | Mouse | IgG1 | Synthetic peptide corresponding to AA 202-216 sequence of human mb-1 | ||
DMAb-0291-CQ | IGA/515 | Mouse | Human | IgG1, κ | Recombinant full-length human IGA protein | |
DMAb-0292-CQ | IGA/764 | Mouse | Human | IgG1, κ | Recombinant human IGA protein |
There are currently no customer reviews or questions for Anti-CD79A DNA-encoded mAb (DMAb), pVAX1 (DMAb-2763-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION